Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 03 tags : Cancer save search
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China
Published: 2021-08-03 (Crawled : 21:00) - biospace.com/
YI | $1.05 -3.67% -1.87% 12K
|
Retail Trade
|
| O: -0.49%
H: 7.83%
C: 5.38%
china cancer liver
LIXTE BIOTECHNOLOGY’S LB-100 ELICITS ANTI- TUMOR ACTIVITY IN SMALL LUNG CANCER MODELS BY UNIQUE MECHANISMS IN AN IMPORTANT PRE-CLINICAL STUDY
Published: 2021-08-03 (Crawled : 14:00) - globenewswire.com
LIXT | $3.28 1.86% 9.55% 16K
|
Health Technology
|
| O: 18.15%
H: 24.54%
C: -14.76%
lung cancer unique pre-clinical cancer biotech technology iot preclinical
Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
Published: 2021-08-03 (Crawled : 13:15) - prnewswire.com
SRNE | $0.02 33.33% -8.85% 97K
|
Health Technology
|
| O: -0.48%
H: 0.72%
C: -1.33%
REPL | $6.33 -1.4% -1.58% 630K
|
Health Technology
|
| O: 0.84%
H: 3.45%
C: 1.78%
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -0.24%
H: 1.98%
C: -1.74%
immunotherapy therapy cancer
Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes
Published: 2021-08-03 (Crawled : 13:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K
|
Health Technology
|
| O: 0.96%
H: 1.65%
C: -1.82%
ORGS | $0.502 -3.28% -3.8% 36K
|
Health Technology
|
| O: -0.6%
H: 0.8%
C: 0.4%
cancer ovarian cancer
Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β Superfamily Member for the Treatment of Cancer
Published: 2021-08-03 (Crawled : 11:00) - biospace.com/
ABCL | $3.9 -1.76% -1.79% 1.5M
|
|
| O: 1.14%
H: 0.0%
C: -1.56%
treatment cancer antibody collaboration
SpringWorks Therapeutics Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patients with Advanced Solid Cancers Harboring MAPK-Activating Mutations
Published: 2021-08-03 (Crawled : 11:00) - globenewswire.com
SWTX | $43.38 -1.41% -1.45% 500K
|
Health Technology
|
| O: 0.15%
H: 1.09%
C: 0.21%
phase 1 cancer trial phase 1b phase 2b
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.